Drugs / human interferon-α
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01341158 | Apr 2011 → Mar 2013 | metastatic melanoma | University Hospital Tuebingen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human interferon-α | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01341158 ↗ |
| Modality | Protein / enzyme biologic | “natural interferon-α (Multiferon)” NCT01341158 ↗ |
| Route | Subcutaneous | “subcutaneously” NCT01341158 ↗ |